vTv Therapeutics Files 8-K for Regulation FD Disclosure
Ticker: VTVT · Form: 8-K · Filed: Sep 10, 2025 · CIK: 1641489
| Field | Detail |
|---|---|
| Company | Vtv Therapeutics Inc. (VTVT) |
| Form Type | 8-K |
| Filed Date | Sep 10, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulation-fd, disclosure
Related Tickers: VTVT
TL;DR
vTvT filed an 8-K for a Reg FD disclosure on Sept 10, 2025.
AI Summary
vTv Therapeutics Inc. filed an 8-K on September 10, 2025, to report a Regulation FD Disclosure. The filing does not contain specific details about the nature of the disclosure, but it is a current report required by the SEC.
Why It Matters
This filing indicates that vTv Therapeutics is making a public disclosure under Regulation FD, which ensures fair disclosure of material information to all investors.
Risk Assessment
Risk Level: low — The filing is a standard procedural disclosure and does not contain information about significant financial events, operational changes, or market-moving news.
Key Players & Entities
- vTv Therapeutics Inc. (company) — Registrant
- September 10, 2025 (date) — Date of Report
- Regulation FD (regulation) — Disclosure Type
- Delaware (jurisdiction) — State of Incorporation
- 001-37524 (file_number) — SEC File Number
- 47-3916571 (ein) — IRS Employer Identification No.
- High Point, NC (location) — Principal Executive Offices
FAQ
What specific information is being disclosed under Regulation FD?
The filing does not specify the exact nature of the Regulation FD disclosure, only that it is being made on September 10, 2025.
What is the purpose of a Regulation FD Disclosure?
Regulation FD requires that when a public company discloses material nonpublic information to securities market professionals or holders of the company's securities who might trade on that information, it must make public disclosure of that information.
When was vTv Therapeutics Inc. incorporated?
vTv Therapeutics Inc. was incorporated in Delaware.
What is the principal executive office address for vTv Therapeutics Inc.?
The principal executive offices are located at 3980 Premier Drive, Suite 310, High Point, NC 27265.
What is the SEC file number for vTv Therapeutics Inc.?
The SEC file number for vTv Therapeutics Inc. is 001-37524.
Filing Stats: 495 words · 2 min read · ~2 pages · Grade level 10.9 · Accepted 2025-09-10 13:03:22
Key Financial Figures
- $0.01 — stered Class A common stock, par value $0.01 per share VTVT Nasdaq Capital Market
Filing Documents
- vtvt-20250910.htm (8-K) — 22KB
- 0001641489-25-000055.txt ( ) — 133KB
- vtvt-20250910.xsd (EX-101.SCH) — 2KB
- vtvt-20250910_lab.xml (EX-101.LAB) — 21KB
- vtvt-20250910_pre.xml (EX-101.PRE) — 12KB
- vtvt-20250910_htm.xml (XML) — 3KB
01 Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure On September 10, 2025, vTv Therapeutics, Inc., (the "Company") will participate in a fireside chat from 2:35 PM - 3:10 PM EST during the Morgan Stanley 23rd Annual Global Healthcare Conference. The fireside chat will be hosted live via audio webcast and will also be available on demand. A link to the live web hosted fireside chat will posted on the Company's web site. The information in this Item 7.01 shall not be deemed to be "filed" for purposes of, or otherwise subject to the liabilities of, Section 18 of the Exchange Act, nor shall it be deemed to be incorporated by reference in any filing under the 33 Act or the Exchange Act, except as shall be expressly set forth by specific reference in any such filing.
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized. VTV THERAPEUTICS INC. By: /s/ Paul J. Sekhri Name: Paul J. Sekhri Title: President, Chief Executive Officer and Executive Chairperson Dated: September 10, 2025